Group 1 - Monteverde & Associates PC is investigating Entero Therapeutics, Inc. regarding its proposed merger with Journey Therapeutics, Inc., where Journey shareholders will acquire 99% of Entero's equity [1] - Monteverde & Associates PC has a successful track record in recovering millions for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report [1][2] - The firm operates from the Empire State Building in New York City and emphasizes its experience in class action securities litigation [2][3] Group 2 - The firm encourages shareholders of Entero Therapeutics to reach out for additional information or concerns regarding the merger [3] - Contact information for Juan Monteverde, Esq. is provided for shareholders seeking legal assistance [4]
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Entero Therapeutics, Inc. – ENTO